164 related articles for article (PubMed ID: 15478042)
1. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
2. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
[TBL] [Abstract][Full Text] [Related]
3. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
4. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
[TBL] [Abstract][Full Text] [Related]
5. Abdominal obesity and expression of familial combined hyperlipidemia.
van der Kallen CJ; Voors-Pette C; de Bruin TW
Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
de Graaf J; van der Vleuten G; Stalenhoef AF
Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632
[TBL] [Abstract][Full Text] [Related]
7. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
8. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
9. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and expression of familial combined hyperlipidemia in childhood.
Cortner JA; Coates PM; Gallagher PR
J Pediatr; 1990 Apr; 116(4):514-9. PubMed ID: 2319396
[TBL] [Abstract][Full Text] [Related]
11. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
[TBL] [Abstract][Full Text] [Related]
12. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
13. Carotid distension and distensibility impairment in individuals affected by familial combined hyperlipidemia.
Montalcini T; Gorgone G; Gazzaruso C; Pujia A
Atherosclerosis; 2010 Sep; 212(1):177-80. PubMed ID: 20542511
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
15. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
16. Familial combined hyperlipidemia and insulin resistance.
Frohlich J; Sniderman A
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2100-1. PubMed ID: 11742892
[No Abstract] [Full Text] [Related]
17. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
Steinmetz A; Schäfer JR
Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
[TBL] [Abstract][Full Text] [Related]
18. Pulse wave velocity in familial combined hyperlipidemia.
ter Avest E; Holewijn S; Bredie SJ; van Tits LJ; Stalenhoef AF; de Graaf J
Am J Hypertens; 2007 Mar; 20(3):263-9. PubMed ID: 17324737
[TBL] [Abstract][Full Text] [Related]
19. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia in young Japanese children: its relation to familial hypercholesterolemia and familial combined hyperlipidemia.
Ohta T; Kiwaki K; Endo F; Umehashi H; Matsuda I
Pediatr Int; 2002 Dec; 44(6):602-7. PubMed ID: 12421255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
